Functional assessment in bone - osteoclast markers

Trial Profile

Functional assessment in bone - osteoclast markers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Maraciclatide (Primary)
  • Indications Osteitis deformans
  • Focus Diagnostic use
  • Acronyms FAB-O study
  • Most Recent Events

    • 04 Nov 2015 Accrual to date is 8% according to United Kingdom Clinical Research Network record.
    • 16 Oct 2015 Status changed from not yet recruiting to recruiting as reported by United Kingdom Clinical Research Network.
    • 11 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top